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Abstract
Background:    Recent  studies  of  viral  entry  proteins  from  influenza,  measles,  human
immunodeficiency virus, type 1 (HIV-1), and Ebola virus have shown, first with molecular modeling,
and then X-ray crystallographic or other biophysical studies, that these disparate viruses share a
coiled-coil type of entry protein.
Results:  Structural models of the transmembrane glycoproteins (GP-2) of the Arenaviruses,
lymphochoriomeningitis virus (LCMV) and Lassa fever virus, are presented, based on consistent
structural propensities despite variation in the amino acid sequence. The principal features of the
model, a hydrophobic amino terminus, and two antiparallel helices separated by a glycosylated,
antigenic apex, are common to a number of otherwise disparate families of enveloped RNA viruses.
Within the first amphipathic helix, demonstrable by circular dichroism of a peptide fragment, there
is a highly conserved heptad repeat pattern proposed to mediate multimerization by coiled-coil
interactions. The amino terminal 18 amino acids are 28% identical and 50% highly similar to the
corresponding region of Ebola, a member of the Filovirus family. Within the second, charged helix
just prior to membrane insertion there is also high similarity over the central 18 amino acids in
corresponding regions of Lassa and Ebola, which may be further related to the similar region of
HIV-1 defining a potent antiviral peptide analogue.
Conclusions:  These findings indicate a common pattern of structure and function among viral
transmembrane fusion proteins from a number of virus families. Such a pattern may define a viral
transmembrane superfamily that evolved from a common precursor eons ago.
Background
Findings in a number of laboratories have indicated that
the transmembrane (TM) proteins of a number of RNA
viruses have common structural and functional elements
critical for virus entry. These include a hydrophobic re-
gion designated a "fusion peptide", usually at or near the
amino-terminus generated by cleavage of a precursor
protein, together with fibrous structure defined by two
antiparallel alpha helices. These general principles ap-
pear to apply to the Orthomyxoviruses, Paramyxovirus-
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es, Retroviruses, Lentiviruses, and Filoviruses [1,2,3,4].
In some cases, such as between Ebola and Rous sarcoma
viruses, there is considerable sequence identity to facili-
tate a comparison between two specific viruses [4]. In
other cases, even within a single virus family such as the
Retroviridae, both structural modeling and more limited
sequence similarity must be combined to discern the re-
lationship [3]. The finding of close sequence or structural
similarity among otherwise disparate virus families has
given rise to the concept of a viral TM superfamily shar-
ing common structural and functional motifs [4]. Recent
biophysical studies of entry protein structure have rein-
forced this concept [5,6].
In this respect, a general model of the Arenavirus glyco-
proteins, based on extensive study of lymphocytic chori-
omeningitis virus (LCMV) has been presented based on
their overall similarity in functional organization to in-
fluenza and to other enveloped viruses. The GP-C pre-
cursor is proteolytically cleaved near a polybasic site to
yield GP-1, a globular surface glycoprotein which con-
tains receptor-binding sites, and GP-2, a TM protein
forming the stalk of the complex via a coiled coil of am-
phipathic helices and responsible for virus entry by acid-
dependent membrane fusion [7,8,9,10].
We present here a detailed model of GP-2 for Lassa fever
virus, an Arenavirus associated with multiple epidemics
of hemorrhagic fever with high morbidity and mortality
in West Africa [11,12], and for the related lymphocytic
choriomeningitis virus (LCMV) which has been associat-
ed with sporadic outbreaks of human disease in Europe
and North America [12]. This model demonstrates that
Arenaviruses share a number of specific sequence and
structural motifs with other RNA viruses in the TM su-
perfamily. Regions of Arenavirus GP-2 can be directly re-
lated to corresponding regions of Ebola, another agent of
African hemorrhagic fever, and to HIV-1. Examination of
the comparable regions of TM proteins from several vi-
rus families provides evidence suggesting divergence
from a common ancestor.
Results and Discussion
The detailed model of LCM and Lassa fever virus GP-2 is
shown in Figure 1. As shown previously for other mem-
bers of the TM superfamily, both consist of two antipar-
allel helices separated by a disulfide-linked apex. The
sequence of GP-2 contains a highly conserved hydropho-
bic sequence, LAGTFTWTL (in LCM) or LLGTFTWTL
(in Lassa), in the vicinity of the post-translational cleav-
age site, with a canonical fusion tripeptide Gly-X-Phe.
However, its candidacy as a functional fusion peptide,
analogous to those of influenza, measles and HIV-1, has
been questioned due to its weakly hydrophobic character
and the fact that actual cleavage occurs, as shown in the
models, not at the dibasic amino acids but within the hy-
drophobic site [13,14]. LCM virus does employ an acid
dependent fusion event to enter the cell but virion-cell
fusion is inactive above pH 6, and the Arenaviruses have
never been demonstrated to exhibit cell-cell fusion.
While this amino-terminus may not be a good candidate
for a classical fusion peptide, its hydrophobic nature and
position suggest that it may at least be the vestige of one.
The region prior to the first helix consists first of a gly-
cine-serine rich linker, and then a domain that is highly
conserved among all Arenaviruses and contains four
cysteines. Only the last of these four is conserved be-
tween the Filoviruses and Arenaviruses. We have not as-
signed disulfide linkages for these since there are neither
data nor parallels with other viruses to permit such as-
signments. Since there is no disulfide cross-linkage with
GP-1, these must participate in disulfide bonding within
the same GP-2 protein, or in cross-linking GP-2 oligom-
ers. The latter possibility is suggested by the kinetics of
GP-2 association with experimental addition of reducing
agent, indicating first a change in vitro from tetramers to
dimers and then to monomers only after considerable
additional reduction [8]. Whether the native multimeric
form of GP-2 in the virion may be a trimer, as for the fu-
sion glycoproteins of Retroviruses or Filoviruses, is yet to
be determined.
The amino-terminal helices of both consist of extended
amphipathic arrays with strong heptad repeats that have
been previously noted [15], and are thought to form the
backbone of the coiled-coil stalk of the viral glycoprotein
complex [16] A peptide analogue of this extended heptad
repeat in LCMV, GP-C 326-355, was examined by circu-
lar dichroism under different solvent conditions, as
shown in Table 1. The peptide exhibited only limited heli-
city in aqueous solution, but 79% alpha helix in a neutral
hydrophobic environment. This biophysical behavior is
reminiscent of that of other similar peptides derived
from the corresponding sequences of Paramyxoviral or
Retroviral TM proteins [2,17].
Comparison of the sequences of Lassa and LCM over this
amphipathic heptad-repeat region (below) shows 31
identical of 58 amino acids, with the principal areas of
conservation of sequence at the amino- and carboxy-ter-
minal ends of the amphipathic helix.
The middle 25 amino acids appear poorly conserved,
with only 6 of 25 identical, yet the character of the aminoBMC Microbiology (2001) 1:1 http://www.biomedcentral.com/1471-2180/1/1
acids substituted is generally conserved. In particular,
while none of the central 4 heptad amino acids (under-
lined and in bold) are identical in each virus, in all cases
the hydrophobic character of the heptad repeat is main-
tained.
The apical domain is the only region to be glycosylated,
also in line with a number of TM proteins including that
of HIV-1 and other Retroviruses. The apical sequence,
particularly the peptide KFWYL in LCMV or KYWYL in
Lassa, defines a broadly-cross reactive antibody epitope
shared by these viruses [18] that is in precisely the same
topographical location as the broadly-reactive apical
epitope (positions 598-609, LGIWGCSGKLIC) that has
been finely mapped in HIV-1 [19]. Also like that in HIV-
1, it is responsive to multimer conformation, and in-
creasingly exposed after receptor binding that results in
release of the binding subunit, GP-1 [13].
The second helical region has properties similar to that
of the Retroviruses and Filoviruses, in that it is highly
charged (30%) and amphipathic, with its helicity possi-
bly stabilized by multiple ion pairings of acidic and basic
residues, as first noted for the corresponding region of
HIV-1 [3]
Although Lassa fever and Ebola viruses represent differ-
ent virus families, both helices share an unexpectedly
high sequence homology. The first lies in the amino-ter-
minal half of the extended amphipathic helix. As shown
in a concentric helical wheel projection in Figure 2A,
when the helices are oriented with respect to the exclu-
sion of charge and the heptad repeats for each sequence,
9 identical or highly similar amino acids (50%) may be
aligned in each sequence.
The carboxy-terminal helical region also has properties
in common with the similarly located helices in both Las-
Figure 1
Models of the Transmembrane Proteins GP-2 of Lassa Virus and LCMV. Projections of the model structure for GP-
2 of Lassa and LCMV are shown in parallel with one another, based on the consensus structures for algorithms of both viral
amino acid sequences. Proposed helices are shown in helical net projection with sequential amino acids connected by solid
lines. Proposed disulfide linkages are indicated by double lines. Hydrophobic amino acids are grouped with a solid background;
neutral amino acids with a heavily outlined circle; hydrophilic amino acids with a light circle; glycosylation sites indicated by tri-
dents. A heavy solid line indicates the point of proteolytic cleavage of the GP-C precursor protein to yield GP-1 and GP-2.
Cysteines are highlighted by larger red circles. The surface membrane of the virus is indicated by a solid purple rectangle, the
amino-terminal hydrophobic region by a yellow rectangle, and the conserved B-cell epitope by a blue rectangle. The two pro-
posed antiparallel helices are labeled "AmphiHelix" for the extended heptad repeat, and "CPI Helix" for the charged, pre-inser-
tion helix.BMC Microbiology (2001) 1:1 http://www.biomedcentral.com/1471-2180/1/1
sa and Ebola, shown as a concentric helical wheel projec-
tion in Figure 2B. Again, orienting the helix with respect
to the hemicylindrical exclusion of charge, 9 identical or
highly similar amino acids (50%) may be aligned. Fur-
thermore, none of the amino acid differences represent a
radical change of one sequence from the other.
Arenaviruses therefore share with a number of other vi-
rus families a fusion/entry protein GP-2 that appears to
have the four cardinal structural features typical of pro-
teins in the viral transmembrane entry protein super-
family. Our model of the extramembranal portion of GP-
2 begins with a hydrophobic fusion peptide sequence,
followed by two antiparallel extended helices, the first of
which contains a strong heptad repeat sequence, which
lie on either side of a disulfide-stabilized, glycosylated
and strongly antigenic reverse turn. These features have
been apparently maintained in spite of diversity in pri-
mary amino acid sequence within the Arenavirus family.
Figure 2
Concentric Helical Wheel Projections of Proposed Lassa and Ebola Helices. Helical wheel projections are shown
for 18 amino acid segments of the proposed helices of Lassa and Ebola viruses. The projections are arranged concentrically to
align the viral sequences, with the inner sequence that from Lassa virus, and the outer sequence from Ebola. Zaire virus (Gen-
bank U31033). Rectangles indicate identical or highly similar residues in each sequence. Heavy lines indicate the hemicylinder of
charge  exclusion  (hydrophobic)  subtending an  angle  of 160°  in each  alignment.  Below  each  wheel  projection  the  linear
sequences are also aligned to show the identities (solid lines) and high similarities (dotted lines). A. Concentric alignment of the
amino terminal amphipathic helices ("lower amphi") of Lassa (amino acids 309-326, in wheel positions 1-18 respectively) and
Ebola (555-572). B. Concentric alignment of the charged, pre-insertion helices ("CPI Helix") of Lassa (398-415) and Ebola (618-
635).
Table 1: Circular Dichroism Spectroscopy of Peptide GPC 326-
355
Θ 222 (deg cm2 
dmol-1)
% alpha helicity 
(100%=32,000)
Aqueous Neutral 4523 14.1
Acid 3777 11.8
TFE Neutral 25314 79.1
Acid 11565 36.1
Circular Dichroism and calculated per cent alpha helix for the peptide 
derived from the LCM sequence NKAALSKFKEDVESALHLFKT-
TVNSLISDQ, as described in Materials and Methods.BMC Microbiology (2001) 1:1 http://www.biomedcentral.com/1471-2180/1/1
Conclusions
The most likely explanation for such high levels of simi-
larity among Arenaviruses and Filoviruses would be di-
vergence of both of these agents from a common viral
ancestor. Since both virus families exhibit type variation
over large areas coupled with stability among isolates
within a more limited geographical area over considera-
ble periods of time (the Arenaviruses being the more
widespread) such divergence must have occurred eons
ago. The potential importance of such apparent conser-
vation in the biology of these agents is underscored by
noting that of the corresponding peptide sequences with-
in the TM superfamily of proteins, that for HIV-1 forms
the center of a peptide analogue shown to inhibit fusion
in the nanomolar range [20].
Modeling studies begun in the late 1980s have thus re-
vealed a number of common and sequence motifs, subse-
quently shown in several cases to have homologous
biological roles in infection, that were not otherwise ap-
parent in studies of sequence homology. These models
may lead to a common strategy of antiviral inhibition
preventing entry of virus into host cells that is broadly
applicable over a broad range of very diverse virus fami-
lies.
Materials and Methods
Molecular Modeling
Sequences used for this analysis were LCMV - ARM
(Genbank P09991) and Lassa, Josiah (Genbank
P08669), and are numbered from the initiation methio-
nine. Detailed models of the Arenavirus GP-1 proteins
were determined by the methods of Gallaher et al. previ-
ously described [3,4,21] A consensus of several inde-
pendent structural algorithms is used, and compared for
different GP-2 sequences to test the consensus. The re-
sulting model is an average consensus of the algorithms
for these two sequences. Models are projected in helical
net or helical wheel projections also as previously de-
scribed.
Peptide Synthesis and Circular Dichroism
A peptide corresponding to amino acid positions 326-
355 of LCMV-ARM-4 (Genbank VGXPLM) in single let-
ter code, NKAALSKFKEDVESALHLFKTTVNSLISDQ,
with an additional histidine at the N terminus was syn-
thesized by standard BOC chemistry using double cou-
pling and HF cleavage. The peptide was purified by
reverse phase HPLC on a C-18 column and the peptide's
weight confirmed by mass spectroscopy. The peptide was
selected as predicted by the Lupas algorithm [22] to have
a greater than 90% probability of forming a heptad re-
peat in the native protein structure. Peptide samples for
circular dichroism (CD) were prepared at 0.1 mg/ml con-
centrations in either 1 mM NaCO3, pH 7.2 (Neutral) or in
100 mM MES, pH 5.5 (Acid). In spectra recorded with
TFE, the TFE was present as 45% of solution volume. CD
spectra were recorded from 300-180 nm with 0.5 nm
steps with a pathlength of 0.1 cm and at 4° C. Final values
were determined using the average of 15 spectra which
were correlated with baseline spectra of buffer samples.
A characteristic alpha helical spectrum was apparent for
the peptide when placed in TFE with a positive peak at
195 nm (Θ  = +43000) and a second minimum peak at
210 nm (Θ  = -25000).
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